Amanta Healthcare IPO Last Date, Price & Prospectus PDF

➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
Amanta Healthcare has released IPO and all details of IPO such as last date to apply, price, prospectus PDF and all other details are given below.
Amanta Healthcare IPO Details
IPO Open Date | September 1, 2025 |
IPO Close Date | September 3, 2025 |
Face Value | ₹10 Per Equity Share |
IPO Price Band | ₹120 to ₹126 Per Share |
Issue Size | Approx ₹126 Crores |
Fresh Issue | Approx ₹126 Crores |
Lot Size | 119 Shares |
Issue Type | Book Built Issue |
IPO Listing | BSE & NSE |
Retail Quota | Not more than 35% |
QIB Quota | Not more than 50% |
NII Quota | Not more than 15% |
Download Prospectus PDF | Click Here |
Amanta Healthcare IPO Dates and Schedule
IPO Open Date | September 1, 2025 |
IPO Close Date | September 3, 2025 |
Basis of Allotment | September 4, 2025 |
Refunds | September 5, 2025 |
Credit to Demat Account | September 5, 2025 |
IPO Listing Date | September 8, 2025 |
About Amanta Healthcare IPO
Amanta Healthcare Limited, established in December 1994, is a pharmaceutical company engaged in developing, manufacturing, and marketing a wide range of sterile liquid products, mainly parenterals. These products are packed in plastic containers using advanced technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM). The company’s product range includes IV fluids, diluents, eye drops, and respiratory care solutions under its fluid therapy segment.
In addition, Amanta Healthcare manufactures irrigation solutions, first-aid products, and eye lubricants as part of its medical devices division. The company sells its products through three main divisions—National Sales, International Sales, and Product Partnerships with both Indian and global pharmaceutical companies. It also produces more than 45 generic products under its own brand, which are distributed in India through 320 distributors and stockists. As of March 31, 2025, the company has 1,718 employees.